[HTML][HTML] New approaches to targeting the androgen receptor pathway in prostate cancer

PI Velho, DA Bastos, ES Antonarakis - hematologyandoncology.net
The androgen signaling axis has been the main therapeutic target in the management of
advanced prostate cancer for several decades. Over the past years, significant advances …

New approaches to targeting the androgen receptor pathway in prostate cancer

PI Velho, DA Bastos… - Clinical Advances in …, 2021 - experts.umn.edu
The androgen signaling axis has been the main therapeutic target in the management of
advanced prostate cancer for several decades. Over the past years, significant advances …

New approaches to targeting the androgen receptor pathway in prostate cancer

PI Velho, DA Bastos… - Clinical advances in …, 2021 - pubmed.ncbi.nlm.nih.gov
The androgen signaling axis has been the main therapeutic target in the management of
advanced prostate cancer for several decades. Over the past years, significant advances …

New approaches to targeting the androgen receptor pathway in prostate cancer

PI Velho, DA Bastos… - Clinical Advances in …, 2021 - pure.johnshopkins.edu
The androgen signaling axis has been the main therapeutic target in the management of
advanced prostate cancer for several decades. Over the past years, significant advances …

New approaches to targeting the androgen receptor pathway in prostate cancer.

PI Velho, DA Bastos, ES Antonarakis - Clinical Advances in …, 2021 - europepmc.org
The androgen signaling axis has been the main therapeutic target in the management of
advanced prostate cancer for several decades. Over the past years, significant advances …